medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2008, Number 09

<< Back Next >>

Ginecol Obstet Mex 2008; 76 (09)

Anemic syndrome frequency in complicated obstetrical patients

Veloz MMG, Cruz EL, García MC, Basavilvazo RMA, Hernández VM

Language: Spanish
References: 18
Page: 537-541
PDF size: 184.38 Kb.


ABSTRACT

Background: The prevalence of anemia varies from country to country and there is not a trustworthy record.
Objective: To determine the frequency of anemia in obstetric patients and the association among healthy pregnancy and aggregate complications.
Patients and method: Was carried out as transversal, observational and comparative study. Obstetrical patients entered and responded in the period of a year, were formed a group with normal pregnancy and another with complicated pregnancy, with a total sample of 194 patients. In the statistical analysis was employed Student t test for independent groups, with value if p ‹ 0.05.
Results: When was included all patients from both groups of study a general frequency of anemia was found in 22.4%. Hematological stage from group with normal pregnancy was mild anemia in 16.9% and anemia moderated in 4.1% of the cases. The anemia degrees in the group with associated illness and pregnancy were mild anemia in 19.2% and moderated anemia in 4.2%. Not any case was found with severe anemia. The statistical analysis showed difference significant among both groups p ‹ 0.05. The most frequently causes of the obstetrical morbidity were preeclampsia severe (22.6%), type 2 diabetes (13.9%), gestational diabetes (12.2%) and the remainder with other complications that include to the hypertiroidism, rheumatoid arthritis, lupus, asthma and vein deep thrombosis.
Conclusions: Frequency of anemia in this study was greater upon informing in the international literature. The obstetrical complication more frequently relates to diverse anemia degrees were the hypertensive stage during pregnancy. The anemia is presented with greater frequency in pregnancy patients with others associated illness.


REFERENCES

  1. Lindblade KA, Mwololo K, Van Eijk AM, Peterson E, et al. Evaluation of the WHO haemoglobin colour scale for diagnosis of anaemia in children and pregnant women as used by primary health care nurses and community health workers in western Kenya. Trop Med Int Health 2006;11(11):1679-87.

  2. Centers for Disease Control. CDC criteria for anemia in children and childbearing age women. MMWR 1989;38:400-5.

  3. Martínez H, González CT, Flores M. Anemia en mujeres en edad reproductiva. Resultados de una encuesta probabilística nacional. Salud Pública Méx 1995;37:108-12.

  4. Gutiérrez RM. Prevalencia de anemia en mujeres con embarazo normal de una población urbana. Rev Med Hosp Gen 1997;60:20-23.

  5. Peck TM, Arias F. Hematologic changes associated with pregnancy. Clin Obstet Gynecol 1979;22:785-8.

  6. Rovinsky JJ, Jaffin H. Cardiovascular hemodynamics in pregnancy. Blood and plasma volume changes in multiple pregnancy. Am J Obstet Gynecol 1965;93:1-5.

  7. Mukhopadhyay A, Bhatla N, Kriplani A, Saxena R. Physiological macrocytosis of pregnancy. Trop Doct 2007;37:42-43.

  8. Ziaei S, Norrozi M, Faghihzadeh S, Jafarbegloo E. A randomised placebo-controlled trial to determine the effect of iron supplementation on pregnancy outcome in pregnant women. BJOG 2007;114:684-8.

  9. Allen LH. Nutritional Suplementation for the pregnant woman. Clin Obstet Gynecol 1994;37:587-9.

  10. Beard L. Iron deficiency assessment during pregnancy and its importance in pregnant adolescents. Am J Clin Nutr 1994;59:502-4.

  11. Finch CA, Cook JC. Iron deficiency. Am J Clin Nutr 1984;39:471-6.

  12. López JA, Schnee M, Gaos CM. Left ventricular outflow tract obstruction and haemolytic anemia after mitral valve repair with a Duran ring. Ann Torac Surg 1994;58:879-82.

  13. Sifakis S, Angelakis E, Papadopoulou E, Stratoudakis G, Fragouli Y, Koumantakis E. The efficacy and tolerability of iron protein succinylate in the treatment of iron-deficiency anemia in pregnancy. Clin Exp Obstet Gynecol 2005;32:117-22.

  14. Hibbard BM. The role of the folic acid in pregnancy. J Obstet Gynecol Br Common 1964;71:529-32.

  15. Streiff RR, Little AB. Folic acid deficiency in pregnancy. N Engl J Med 1967;276:776-9.

  16. Kirke PN, Daly LE, Elwood JH. A randomized trial of low dose folic acid to prevent neural tube defects. Arch Dis Child 1992;67:1442-6.

  17. Organización Panamericana de la Salud-Organización Mundial de la Salud. Estrategias de la OPS-OMS para el control de la deficiencia de hierro en la región. Oficina Sanitaria Panamericana Regional de la Organización Mundial de la Salud. Washington: HPP-HPN 1996;pp:6-12.

  18. Secretaria de Salud. Norma Oficial Mexicana para la atención de la mujer durante el embarazo, parto y puerperio y del recién nacido. Diario Oficial de la federación NOM- 007-SSA-1993.




2020     |     www.medigraphic.com